SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001823239-23-000073
Filing Date
2023-07-20
Accepted
2023-07-20 16:19:15
Documents
4
Period of Report
2023-07-20

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_168988433642387.html 3  
1 FORM 3 wf-form3_168988433642387.xml 3 1762
2 JOHN DEFORD POA exhibit241section16power.htm EX-24 5161
3 JOHN DEFORD POA IMAGE 1 exhibit241section16power001.jpg GRAPHIC 257224
4 JOHN DEFORD POA IMAGE 2 exhibit241section16power002.jpg GRAPHIC 68747
  Complete submission text file 0001823239-23-000073.txt   457499
Mailing Address C R BARD INC 730 CENTRAL AVENUE MURRAY HILL NJ 07974
Business Address
DeFord John A (Reporting) CIK: 0001403373 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39725 | Film No.: 231100067

Mailing Address 10770 WATERIDGE CIRCLE SUITE 200 SAN DIEGO CA 92121
Business Address 10770 WATERIDGE CIRCLE SUITE 200 SAN DIEGO CA 92121 (858) 546-0004
MARAVAI LIFESCIENCES HOLDINGS, INC. (Issuer) CIK: 0001823239 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations